Clinical Trial

Post-market Surveillance of Micorport CRM Cardiac Implantable Electronic Devices

Study acronym: PIANO
Recruiting
View on ClinicalTrials.gov →
Summary
The primary objective of the study is to assess the chronic safety of MicroPort CRM market-released systems.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-01-20.
Status change: Not Yet Recruiting → Recruiting 2024-01-12
Trial Details
NCT Number NCT05694572
Lead Sponsor MicroPort CRM
Conditions Cardiac Rhythm Disorder, Heart Failure, Sudden Cardiac Death
Enrollment 2,500 participants
Start Date 2023-10-30
Primary Completion 2031-06-15 (estimated)
Study Completion 2031-06-15 (estimated)
Updated on ClinicalTrials.gov 2024-01-17